Cargando…

Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway

PURPOSE: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fengxia, Yang, Yiying, Wei, Shanyin, Huang, Xiaojing, Peng, Zhijian, Ke, Xiao, Zeng, Zhicong, Song, Yinzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027865/
https://www.ncbi.nlm.nih.gov/pubmed/32103904
http://dx.doi.org/10.2147/DDDT.S242521
Descripción
Sumario:PURPOSE: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induced vascular injuries. Hydrogen sulfide (H(2)S) has been found to exhibit protective effects on HG-induced vascular injuries. Moreover, H(2)S activates PI3K/Akt/eNOS pathway in endothelial cells. Thus, the present study aimed to determine if H(2)S exerts protective effects against HG-induced injuries of human umbilical vein endothelial cells (HUVECs) via activating PI3K/Akt/eNOS signaling. MATERIALS AND METHODS: The endothelial protective effects of H(2)S were evaluated and compared to the controlled groups. Cell viability, cell migration and tube formation were determined by in vitro functional assays; protein levels were evaluated by Western blot assay and ELISA; cell apoptosis was determined by Hoechst 33258 nuclear staining; Reactive oxygen species (ROS) production was evaluated by the ROS detection kit. RESULTS: HG treatment significantly inhibited PI3K/Akt/eNOS signaling in HUVECs, which was partially reversed by the H2S treatment. HG treatment inhibited cell viability of HUVECs, which were markedly prevented by H(2)S or PI3K agonist Y-P 740. HG treatment also induced HUVEC cell apoptosis by increasing the protein levels of cleaved caspase 3, Bax and Bcl-2, which were significantly attenuated by H(2)S or 740 Y-P. ROS production and gp91(phox) protein level were increased by HG treatment in HUVECs and this effect can be blocked by the treatment with H(2)S or Y-P 740. Moreover, HG treatment increased the protein levels of pro-inflammatory cytokines, caspase-1 and phosphorylated JNK, which was significantly attenuated by H(2)S or Y-P 740. Importantly, the cytoprotective effect of H(2)S against HG-induced injury was inhibited by LY294002 (an inhibitor of PI3K/Akt/eNOS signaling pathway). CONCLUSION: The present study demonstrated that exogenous H(2)S protects endothelial cells against HG-induced injuries by activating PI3K/Akt/eNOS pathway. Based on the above findings, we proposed that reduced endogenous H(2)S levels and the subsequent PI3K/Akt/eNOS signaling impairment may be the important pathophysiological mechanism underlying hyperglycemia-induced vascular injuries.